LONP1 and atherosclerosis: The development of allosteric inhibitors and activators of LonP1 will be invaluable in elucidating its mechanistic and functional complexities and holds promise for chemotherapeutic benefit in treating cancers and age-associated disorders such as atherosclerosis and neurodegeneration.